PRAS40 Is an Insulin-Regulated Inhibitor of the mTORC1 Protein Kinase
Top Cited Papers
- 1 March 2007
- journal article
- Published by Elsevier in Molecular Cell
- Vol. 25 (6) , 903-915
- https://doi.org/10.1016/j.molcel.2007.03.003
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Ablation in Mice of the mTORC Components raptor, rictor, or mLST8 Reveals that mTORC2 Is Required for Signaling to Akt-FOXO and PKCα, but Not S6K1Developmental Cell, 2006
- mTOR and cancer: insights into a complex relationshipNature Reviews Cancer, 2006
- Expression of proline-rich Akt-substrate PRAS40 in cell survival pathway and carcinogenesis1Acta Pharmacologica Sinica, 2005
- The hypoxia-induced paralogs Scylla and Charybdis inhibit growth by down-regulating S6K activity upstream of TSC in DrosophilaGenes & Development, 2004
- Inactivation of the Tuberous Sclerosis Complex-1 and -2 Gene Products Occurs by Phosphoinositide 3-Kinase/Akt-dependent and -independent Phosphorylation of TuberinJournal of Biological Chemistry, 2003
- Rheb is a direct target of the tuberous sclerosis tumour suppressor proteinsNature Cell Biology, 2003
- Rheb is an essential regulator of S6K in controlling cell growth in DrosophilaNature Cell Biology, 2003
- The Mammalian Target of Rapamycin (mTOR) Partner, Raptor, Binds the mTOR Substrates p70 S6 Kinase and 4E-BP1 through Their TOR Signaling (TOS) MotifJournal of Biological Chemistry, 2003
- Identification of a Proline-rich Akt Substrate as a 14-3-3 Binding PartnerJournal of Biological Chemistry, 2003
- mTOR Interacts with Raptor to Form a Nutrient-Sensitive Complex that Signals to the Cell Growth MachineryCell, 2002